Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (39)

2024

  1. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32

  2. Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers

    Frontiers in Allergy

  3. Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 3, pp. 192-195

  4. Profile of Patients With Moderate-to-Severe Atopic Dermatitis and Chronic Urticaria Undergoing Biological Treatment in Hospital Allergy Units in Spain: First Report of the Alergodata Registry

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 2, pp. 131-133

2023

  1. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

  2. Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 11, pp. 3407-3413.e1

  3. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288

  4. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases

    Frontiers in immunology, Vol. 14, pp. 1310211

  5. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  6. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti–IL-5 Biologics: A Real-Life Study

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 1, pp. 37-44

  7. Lung Function Abnormalities and Their Correlation With Clinical Characteristics and Inflammatory Markers in Adult Asthma

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 294-296

  8. Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy

    Vaccines, Vol. 11, Núm. 5

  9. Reply to “Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies”

    Journal of Investigational Allergology and Clinical Immunology

2022

  1. Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis

    Immunotherapy, Vol. 14, Núm. 9, pp. 683-694

  2. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 5, pp. 345-356

  3. Safety of COVID-19 vaccination in patients with clonal mast cell disorders

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 5, pp. 1374-1376.e3

2021

  1. Cardiovascular changes during peanut-induced allergic reactions in human subjects

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 2, pp. 633-642

  2. Chronic toxicity and long-term outcome in intraoperative electron radiotherapy as boost followed by whole-breast irradiation

    Clinical and Translational Oncology, Vol. 23, Núm. 8, pp. 1593-1600

  3. Seaic specialty forum: Analysis of the current situation of allergology in spain and outlook for the future

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 120-131

2019

  1. Changes in mammographic density over time and the risk of breast cancer: An observational cohort study

    Breast, Vol. 46, pp. 108-115